Table 1 Pulmonary functions on etodolac and placebo treatments in patients with sinobronchial syndrome.
Run-in | Placebo | Wash out | Etodolac | |
|---|---|---|---|---|
FVCs as % pred. (%) | 106.7 ± 4.3 | 108.8 ± 4.1 | 106.6 ± 4.4 | 112.5 ± 1.2 |
FEV1 s as % pred. (%) | 119.3 ± 5.1 | 118.8 ± 6.1 | 116.5 ± 9.1 | 112.0 ± 9.0 |
FEV1/FVC ratio as % pred. (%) | 76.6 ± 6.0 | 74.6 ± 7.0 | 76.3 ± 6.4 | 72.5 ± 5.4 |